FDA Approved: PROCRIT — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved Janssen Products, LP's supplemental application for PROCRIT (erythropoietin alfa), updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Due to Cancer Chemotherapy
• Anemia Due to Chronic Kidney Disease

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• PROCRIT (ERYTHROPOIETIN)

Snippet

SUPPL AP for PROCRIT (ERYTHROPOIETIN)